Guardant Health Inc (GH)

NASDAQ
50.36
-1.06(-2.06%)
After Hours
51.67
+1.31(+2.60%)
- Real-time Data
  • Volume:
    726,032
  • Day's Range:
    48.71 - 51.34
  • 52 wk Range:
    27.65 - 133.82

GH Overview

Prev. Close
51.42
Day's Range
48.71-51.34
Revenue
408.13M
Open
51.34
52 wk Range
27.65-133.82
EPS
-5.42
Volume
726,032
Market Cap
5.15B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,170,741
P/E Ratio
-9.81
Beta
0.799
1-Year Change
-49.09%
Shares Outstanding
102,220,389
Next Earnings Date
Nov 03, 2022
What is your sentiment on Guardant Health?
or
Market is currently closed. Voting is open during market hours.

Guardant Health Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Guardant Health Inc Analysis

Guardant Health Inc Company Profile

Guardant Health Inc Company Profile

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyNeutralSellSellSell
Technical IndicatorsStrong BuyStrong BuyStrong SellNeutralStrong Sell
SummaryStrong BuyBuyStrong SellNeutralStrong Sell
  • Number one player in the liquid biopsy, but macro enviroment is likely dragging down the price further..?!
    0
    • no divided shares
      0
      • GH has all the right elements to be a $180 stock with a year in a hot segment
        0
        • I am so imptient to see Q3 figures with FDA approval on blood test and covid test 🚀🚀
          0
          • doing well...
            0
            • one of the only stocks to actually have gains......I missed my chance
              0
              • I was right, inept people are written reccomendations for money given by such sh... company like GH.
                3
                • I followed zacks.com reccommendations but simply; worth for nothing (so many others)!
                  1
                  • Hope GH will fall to 30 lol
                    0
                    • this is a tremendous company: it was though impossible to buy at the levels it reached: now it is starting to have some serious upside.
                      1